Cardiovascular Disease (CVD) Completed Phase 3 Trials for Febuxostat (DB04854)

Also known as: Cardiovascular Heart Disease / Cardiovascular Disease (CKD) / Cardiovascular (CV) Disease / Cardiovascular Disease / Cardiovascular Diseases

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01101035Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)Treatment